← FDA Drug Approvals (Drugs@FDA)

OXALIPLATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2012-08-08

Drug application

FDA Application #

ANDA200979

Application type

Abbreviated New Drug Application (Generic)

Brand name

OXALIPLATIN

Generic name

Oxaliplatin

Active ingredients

OXALIPLATIN

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

PHARMOBEDIENT

First approval

2012-08-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown